Saturday 17 October 2026
Export DTIL’s income statement to Excel — free account
Precision BioSciences, Inc.
DTIL Healthcare Biotechnology
Precision BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.3 million, down 50.1% from fiscal 2024. In the quarter to June 2026, revenue grew 37,272.4%, EPS grew 40.9%, free cash flow grew 33.7% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.77
0.40
−6.48%
Follow DTIL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(205.16%) | (61.52%) | (69.52%) | (132.91%) | |
Piotroski F-Score |
1 | 1 | 2 | — | |
| (67.76%) | (31.45%) | (32.50%) | (44.91%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(215.83%) | (41.10%) | (42.69%) | (61.77%) | |
Average Days of Receivables |
2.09 | 0.00 | 32.39 | — | |
Free Cash Flow per Share |
(6.23) | (5.18) | (2.40) | (2.02) | |
Free Cash Flow |
(73.68) | (66.48) | (59.16) | (52.32) | |
Capital Expenditures |
(0.41) | (0.63) | (0.43) | (0.42) | |
| Other line items | |||||
Cash ROIC |
(87.84%) | (28.87%) | (29.62%) | (33.70%) | |
Accounts Receivable Turnover |
6.62 | 0.00 | 21.52 | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7,967.77% | 158.10% | 119.13% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4,954.87% | 94.09% | 67.65% | 0.00% | |
Share Based Compensation of Revenue |
1,678.51% | 29.73% | 19.77% | 0.00% | |
Interest Coverage |
(61.05) | (36.67) | (28.36) | (27.55) | |
Operating CF/Net income |
0.88 | 1.44 | 1.35 | 0.98 | |
Depreciation/Fixed assets |
0.97 | 1.45 | 1.93 | 2.45 | |
Capex/Depreciation |
(0.21) | (0.31) | (0.19) | (0.18) | |
Revenue per Share |
0.06 | 2.67 | 1.83 | 0.00 | |
Operating CF per Share |
(6.20) | (5.13) | (2.38) | (2.01) | |
Capex per Share |
(0.03) | (0.05) | (0.02) | (0.02) | |
Capex to Sales |
0.58 | 0.02 | 0.01 | 0.00 |
Columns are period end dates